Kai Yang

Sr. Research Associate, Chemistry

Kai Yang obtained his B.S. in Pharmacy at Nankai University in 2017. He achieved a M.S. in Medicinal Chemistry at Rutgers University in 2020. He focused on the design, synthesis, and biological evaluation of small-molecule uric acid and dihydroxyadenine inhibitors for the treatment of nephrolithiasis. Kai then joined Chempacific Corporation and developed and drafted clear synthetic strategies for complex molecules using state-of-the-art methodologies. He is eager to apply his knowledge in the basic and clinical sciences to discover and develop novel pharmaceuticals to treat and cure challenging human diseases.

Go to Top